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Abstract
Background: Body image concerns are infrequently studied in systemic sclerosis (SSc), even though significant visible
disfigurement is common. The objective of this study was to identify sociodemographic and disease-related correlates of
dissatisfaction with appearance and social discomfort among people with SSc.
Methods: SSc patients came from the 15-center Canadian Scleroderma Research Group Registry. Sociodemographic
information was based on patient self-report. Disease characteristics were obtained via physician examinations. The Brief-
SWAP was used to assess dissatisfaction with appearance and social discomfort. Structural equation models were
conducted with MPlus to determine the relationship of dissatisfaction with appearance and social discomfort with age, sex,
education, marital status, race/ethnicity, disease duration, skin involvement, telangiectasias, skin pigmentation changes, and
hand contractures.
Results: A total of 489 SSc patients (432 female, 57 male) were included. Extent of skin involvement was significantly
associated with both dissatisfaction with appearance and social discomfort (standardized regression coefficients=0.02,
p=0.001; 0.02, p=0.020, respectively), as was skin involvement in the face (0.18, p=0.016; 0.23, p=0.006, respectively).
Greater social discomfort was robustly associated with younger age (20.017, p,0.001) and upper-body telangiectasias
(0.32, p=0.021). Dissatisfaction with appearance was associated with hand contractures (0.07, p=0.036).
Conclusion: This study found that dissatisfaction with appearance and social discomfort were associated with numerous
disfiguring characteristics of SSc, in addition to age. These results underline that there are multiple factors contributing to
body image distress in SSc, as well as the need to attend to both disease and social contexts in understanding the impact of
disfigurement among patients.
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Introduction
Systemic sclerosis (SSc), or scleroderma, is a multi-system,
chronic autoimmune connective tissue disease characterized by
vascular injury, immune dysfunction, and abnormal fibrotic
processes. SSc affects the skin, as well as internal organs such as
the lungs, heart, and gastrointestinal tract [1]. The rate of disease
onset is highest between 30–50 years of age, and 80% of people
affected are female [2,3]. Median survival time from diagnosis is
approximately 11 years, with patients 3.7 times more likely to die
within 10 years of diagnosis (44.9% mortality) than age, sex, and
race-matched individuals without the disease (12.0% mortality)
[2]. The name scleroderma is derived from the Greek words scleros,
meaning hard, and derma meaning skin. This is because a central
feature of SSc is the excessive production of collagen, which
manifests itself in thickening and hardening of the skin, and
commonly leads to significant visible disfigurements to various
body parts, including the face, mouth, and hands [1].
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a healthy body image and decreased comfort in social interactions,
both of which can lead to anxiety and other forms of distress [4,5].
Research among patients with physical disfigurements has
highlighted that characteristics of the disfigurement, including
severity, visibility, and location of appearance changes, may
influence body image dissatisfaction and related problems [6].
There has been relatively little research on body image distress in
SSc. Nonetheless, existing studies have shown that more severe
disease manifestations, such as significant skin changes in the
hands, are associated with greater body image dissatisfaction,
increased depressive symptoms, and reduced overall psychosocial
functioning, including appearance-related anxiety and social
avoidance [7–9]. One recent study of 171 SSc patients examined
the impact of facial changes, and reported that patients rated facial
disfigurement as the most worrying aspect of the condition [10],
and another study of 129 SSc patients reported that greater
objective disfigurement was linked to more distress, worry, and
perceptions of noticeability by patients [9].
Research from non-disfigured populations has suggested that
women are less satisfied with their appearance than men [6,11],
and generally, studies of body image, broadly defined, report that
women tend to have poorer body image appraisals [12].
Furthermore, in the context of social interactions, particularly
for establishing intimate relationships, appearance is highly
relevant. Thus, appearance concerns are sometimes more salient
for unattached persons compared to those in stable marriages or
intimate relationships [6]. Similarly, concerns with appearance
and its importance for meeting new people and making social
connections is often more pronounced earlier in life, and the
broader literature on people with changes to their appearance due
to illness and injury has reported that older age is generally
associated with less distress related to body image [13].
Patients with SSc may experience significant emotional distress
due to negative self-appraisals or dissatisfaction with their
appearance, discomfort in social situations due to changes in
appearance, or both. Dissatisfaction with appearance and social
discomfort are related, but distinct constructs [14]. The Brief-
Satisfaction with Appearance Scale (Brief-SWAP) [14] was
designed to evaluate both dissatisfaction with appearance and
social discomfort related to disfigurement from SSc. The
Dissatisfaction with Appearance subscale assesses self-reported
dissatisfaction with specific body parts commonly affected by SSc
(face, hands, and arms). The Social Discomfort subscale assesses
the impact of body image concerns on social interactions (e.g.,
comfort with strangers, feelings of unattractiveness to others) [14].
The objective of this study was to identify sociodemographic
(age, sex, marital status, race/ethnicity, and education) and disease
factors (skin involvement, telangiectasias, hand contractures and
disfigurement, and changes in skin pigmentation) associated with
(1) dissatisfaction with appearance and (2) social discomfort among
patients with SSc. We hypothesized that sociodemographic
variables, including age, sex, and marital status, as well as SSc
disease factors, including skin involvement, telangiectasias, hand
contractures, and changes in skin pigmentation would be
potentially associated with dissatisfaction with appearance and
social discomfort.
Methods
Ethics Statement
This study consisted of an analysis of data from within the
Canadian Scleroderma Research Group’s (CSRG) pan-Canadian
Registry. Ethics approval for the Registry and this study was
provided by the research ethics committee of McGill University.
In addition, the research ethics committees of each of the 15
CSRG centres approved data collection for inclusion in the
Registry. All patients provided written informed consent.
Participants and Procedure
The sample consisted of patients who completed annual visits as
part of the CSRG Registry between 2008, when the Brief-SWAP
was first included in the Registry, and 2010. To be eligible for the
Registry, patients must have a diagnosis of SSc made by a Registry
rheumatologist, be $18 years of age, and be fluent in English or
French. Registry patients undergo physician evaluations at their
initial visit and at subsequent yearly visits. Patients were included
in the study if they had complete data for the Brief-SWAP and all
other variables included in analyses. Some patients completed the
Brief-SWAP at more than one visit, but only data from the first
administration were analyzed in this study.
Measures
Dissatisfaction with appearance and social discomfort were
measured by the Brief-SWAP [14]. Sociodemographic variables
included in analyses were assessed by patient self-report and
consisted of age, sex, marital status (married or living as married
versus single, divorced, or widowed), race/ethnicity (white versus
other race/ethnicity), and education (high school or less versus
higher education). Disease-related variables included in analyses
were measured via clinical histories and examinations by study
physicians and consisted of disease duration; total body skin
involvement (modified Rodnan skin score, mRss), as well as body
area-specific skin involvement scores; upper-body telangiectasias;
skin pigmentation changes (hyper-and/or hypo-pigmentation);
and fingertip-to-palm distance to assess hand contractures. In
addition, disease subtype was recorded, but it was not entered into
the analyses because of the high degree of overlap with mRss.
Although over 1,000 variables are collected at each CSRG visit,
only the variables described here were considered for inclusion in
analyses.
The Brief-Satisfaction with Appearance Scale (Brief-
SWAP). The 6-item Brief-SWAP [14] assesses dissatisfaction
with appearance and social discomfort related to disfigurement in
SSc. It was adapted from the original 14-item Satisfaction with
Appearance Scale (SWAP) [15] that was designed to measure non-
weight related body image dissatisfaction among burn survivors.
The Brief-SWAP includes two subscales: Dissatisfaction with
Appearance, reflecting dissatisfaction with the appearance of
specific body parts relevant to patients with SSc (face, hands,
arms), and Social Discomfort, reflecting social discomfort relative
to disfigurement from SSc. Respondents to the Brief-SWAP rate
the degree to which they feel each item reflects their thoughts and
feelings about their appearance on a 7-point scale ranging from 0
(strongly disagree) to 6 (strongly agree). Item scores can be summed to
calculate total subscale scores with higher scores indicating greater
dissatisfaction or social discomfort. The range of possible scores is
0–18 for each subscale. Each subscale of the Brief-SWAP is
comprised of three items. Items from the Dissatisfaction with
Appearance subscale are: (1) I am satisfied with the appearance of
my face, (2) I am satisfied with the appearance of my hands, and
(3) I am satisfied with the appearance of my arms. Items from the
Social Discomfort subscale are (1) Because of changes in my
appearance caused by my scleroderma, I am uncomfortable in the
presence of strangers, (2) I feel that my scleroderma is unattractive
to others, and (3) I don’t think people would want to touch me. In
a previous study of 654 SSc patients from the CSRG Registry,
the internal consistency reliability was good for both the
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(a=0.81) subscales. The Brief-SWAP total score was highly
correlated with the full 14-item SWAP total score (r=0.95), and all
correlations of the Brief-SWAP total score and full SWAP total
score with measures of convergent validity were substantively
equal with no statistically significant differences [14]. The raw sum
scores of the Dissatisfaction with Appearance subscale and Social
Discomfort subscale were only moderately correlated at r=0.46
(correlation of latent factors=0.56) [14], thus, in the current study,
subscale scores, rather than a total score, were used.
Disease-Related Variables. SSc disease duration was
defined as the time from onset of the first non-Raynaud’s
disease symptoms based on clinical history established by study
physicians. Limited/diffuse status was recorded and defined as
per LeRoy’s definition. Limited disease was defined as skin
involvement distal to the elbows and knees with or without face
involvement and diffuse disease as skin involvement proximal to
the elbows and knees and/or involving the trunk [16]. Total body
skin involvement was assessed using the mRss, a previously
validated method that has been used in other SSc samples
[17–21]. Skin involvement is an important component of disease
severity in SSc [17,18]. For each of 17 body areas, physicians rate
the skin from 0 (normal)t o3( hidebound), summing to obtain the
mRss; scores can range in severity from 0 to 51. In addition, to
determine the most salient body areas of potential concern, area-
specific scores were derived for six body regions, including (1) the
face, (2) hands/fingers, (3) arms, (4) chest/abdomen, (5) thighs,
and (6) legs and feet. The area-specific scores were defined by the
maximum severity score for each area (possible maximum score
0–3). For instance, the arms comprised four individual parts (i.e.,
right upper arm, right lower arm, left upper arm, left lower arm),
and we defined the variable ‘‘arms’’ as the highest score from any
of those parts. Telangiectasias were defined as including either
macular or dot telangiectasias, or both; these involve the visible
dilatation of superficial cutaneous blood vessels that collapse upon
pressure and fill slowly when pressure is released, and exclude
normal sun exposure-related telangiectasias. This definition is
based on an adapted definition from Medsger et al. [17], as there
is no uniform, validated definition of telangiectasias.
Telangiectasias were coded separately for the upper body and
lower body as present or absent. However, we used only upper-
body telangiectasias because very few patients had lower-body,
but not upper-body telangiectasias (4 of 390 with any
telangiectasias in the current sample, 1.0%). Hyper- and/or
hypo-pigmentation of the skin were each scored by physicians as
present or absent. For analyses, we coded patients as having any
pigmentation change versus none due to the high degree of
overlap between occurrences of hyper- and hypo-pigmentation.
In the current sample, only 23 of 119 patients with hypo-
pigmentation did not have hyper-pigmentation as well (19.3%).
To determine the presence of possible disfigurement because of
hand contractures, fingertip-to-palm distances of both hands were
measured by asking patients to make a fist, and the distance from
the tip of the finger pad of the third finger to the distal palmar
crease in full flexion was recorded in centimetres. This is a
consistently used surrogate marker of contractures that is based
on established methods [17,18]. In this study, the greater
fingertip-to-palm distance of the right and left hand was used.
Data Analysis
To simultaneously assess correlates of dissatisfaction with
appearance and social discomfort, we used the software MPlus
[22] and replicated the two-factor confirmatory factor analysis
model that was previously reported for the Brief-SWAP (Dissat-
isfaction with Appearance and Social Discomfort) [14]. Item
responses for the Brief-SWAP are ordinal Likert data, so the
weighted least squares estimator with a diagonal weight matrix,
robust standard errors, and a mean-and variance-adjusted chi-
square statistic was used with delta parameterization [22]. A
chi-square goodness-of-fit test and three fit indices were used to
assess model fit, including the Tucker-Lewis Index (TLI) [23];
the comparative fit index (CFI) [24]; and the root mean square
error of approximation (RMSEA) [25]. Since the chi-square test
is highly sensitive to sample size and can lead to the rejection of
well-fitting models, practical fit indices were emphasized [26].
Guidelines proposed by Hu and Bentler [27] suggest that
m o d e l sw i t hT L Ia n dC F Ic l o s et o. 9 5o rh i g h e ra n dt h e
RMSEA close to .06 or lower are representative of good fitting
models. A CFI of .90 or above [28] and a RMSEA of .08 or less
[29] may also be considered to represent reasonably acceptable
model fit.
In an initial model, we regressed the Dissatisfaction with
Appearance and Social Discomfort latent factors on a priori
specified sociodemographic (age, sex, education, marital status,
and race/ethnicity) and disease-related variables (disease duration,
mRss, upper-body telangiectasias, hyper- and/or hypo-pigmenta-
tion, and fingertip-to-palm distance). We removed sociodemo-
graphic and disease-related variables from the model if they were
not associated with the Dissatisfaction with Appearance or Social
Discomfort subscales (p.0.25), if their inclusion worsened overall
model fit, and if their removal did not substantively or significantly
influence links between other sociodemographic or disease
variables and the Brief-SWAP latent factors.
Due to the significant association between mRss and the
Dissatisfaction with Appearance and Social Discomfort subscales,
in order to determine the body areas where skin involvement was
most closely linked to these body image factors, in a second model,
we replaced the mRss with body area-specific scores for the (1)
face, (2) hands/fingers, (3) arms, (4) chest/abdomen, (5) thighs, and
(6) legs and feet. We did this by initially entering the area-specific
scores individually in separate models then including the body
area with the most robust association with each factor.
Subsequently, we kept that body area in the model and added
other areas that were significant, starting with largest associations
first.
Results
Sample Characteristics
A total of 489 patients were included in the study. Socio-
demographic and disease characteristics are presented in Table 1,
as well as Pearson bivariate correlations between sociodemo-
graphic and disease variables and Brief-SWAP subscales. The
mean age of the sample was 57.1 years (SD=11.7, range=21–84
years), 88% of patients were female, and 91% were White. The
mean time since onset of the first non-Raynaud’s disease
symptoms was 10.4 years (SD=8.7), and the mean mRss was
9.0 (SD=8.7; internal consistency a=0.94). Mean mRss was
significantly higher in diffuse (mean=19.2, SD=9.8) compared to
limited disease patients (mean=5.9, SD=4.2; p,0.001). The
Pearson correlation between limited/diffuse status and mRss was
0.65 (p,0.001). As shown in Table 2, Pearson correlations
between body area-specific scores ranged from 0.32 to 0.66. The
mean Dissatisfaction with Appearance subscale score was 8.4
(SD=5.2), and the mean Social Discomfort subscale score was 5.1
(SD=5.1). Both subscales had good internal consistency reliability
(Dissatisfaction with Appearance a=0.82, Social Discomfort
a=0.83).
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Discomfort
In the initial model, mRss was significantly associated with both
greater Dissatisfaction with Appearance (standardized regression
coefficient =0.02, p=0.001) and greater Social Discomfort (0.02,
p=0.020). When we replaced the mRss in the model with body-
specific areas, each was significantly associated with Dissatisfaction
with Appearance and Social Discomfort latent factors (p,0.05)
with face being the most robust. In the final model (see Figure 1),
face skin involvement was significantly associated with both factors
(Dissatisfaction with Appearance, 0.18, p=0.016, Social Discom-
fort, 0.23, p=0.006). Once scores for the face were included in the
model, no other area-specific scores were statistically significant
when added. Model fit was good (x
2(30)=84, CFI=0.99,
TLI=0.98, RMSEA=0.06), and all item factor loadings were
$0.79 for the Dissatisfaction with Appearance factor and $0.67
for the Social Discomfort factor. The correlation between the
Dissatisfaction with Appearance and Social Discomfort factors was
0.59. The model accounted for 13% of the variance in the Social
Table 1. Sociodemographic Variables, Disease Characteristics for SSc Patients, and Pearson Correlations with Brief-SWAP Subscales
(N=489).
Sociodemographic Variables:
Correlation with
Dissatisfaction with
Appearance
Correlation with Social
Discomfort
Age (mean years, SD) 57.1 (11.7) 20.04 (p=0.400) 20.20 (p,0.001)
Female sex (n, %) 432 (88.3) 20.01 (p=0.818) 0.06 (p=0.220)
White (n, %) 447 (91.4) 20.03 (p=0.516) 20.06 (p=0.167)
Married (n, %) 344 (70.3) 20.05 (p=0.306) 20.06 (p=0.205)
Above high school education (n, %) 227 (46.4) 0.05 (p=0.232) 0.01 (p=0.839)
Disease Characteristics:
Disease duration (mean years, SD) 10.4 (8.7) 0.001 (p=0.977) 0.01 (p=0.877)
Limited SSc (n, %) 323 (71.0) 0.16 (p=0.001) 0.21 (p,0.001)
Modified Rodnan Skin Score (0–51) (mean, SD) 9.0 (8.7) 0.24 (p,0.001) 0.23 (p,0.001)
Maximum Skin Scores for Specific Body Areas:
Face (0–3) (mean, SD) 0.6 (0.8) 0.18 (p,0.001) 0.21 (p,0.001)
Right/left hands and right/left fingers (0–3) (mean, SD) 1.7 (1.0) 0.18 (p,0.001) 0.17 (p,0.001)
Right/left upper arms and right/left forearms (0–3) (mean, SD) 0.5 (0.8) 0.20 (p,0.001) 0.20 (p,0.001)
Chest and abdomen (0–3) (mean, SD) 0.2 (0.6) 0.17 (p,0.001) 0.22 (p,0.001)
Right/left thighs (0–3) (mean, SD) 0.4 (1.1) 0.18 (p,0.001) 0.17 (p,0.001)
Right/left lower leg and right/left feet (0–3) (mean, SD) 0.6 (0.9) 0.16 (p,0.001) 0.11 (p=0.013)
Upper-body telangiectasias 386 (78.9) 0.08 (p=0.080) 0.11 (p=0.020)
Hyper- and/or hypo-pigmentation 210 (42.9) 0.14 (p=0.002) 0.18 (p,0.001)
Fingertip-to-palm distance (greater of right and left hands)
(mean cm, SD)
1.0 (1.7) 0.18 (p,0.001) 0.16 (p=0.001)
Body Image:
Brief-SWAP (mean, SD) 13.5 (8.8) ------ ------
Brief-SWAP Dissatisfaction with Appearance Subscale 8.4 (5.2) ------ 0.59 (p,0.001)
Brief-SWAP Social Discomfort Subscale 5.1 (5.1) 0.59 (p,0.001) ------
doi:10.1371/journal.pone.0033281.t001
Table 2. Pearson Correlations between Body Area-Specific Scores
1.
Face Hands and Fingers Arms
Chest and
Abdomen Thighs Legs and Feet
Face 1.00 0.47 0.48 0.43 0.33 0.32
Hands and Fingers 1.00 0.49 0.36 0.35 0.35
Arms 1.00 0.63 0.65 0.44
Chest and Abdomen 1.00 0.66 0.38
Thighs 1.00 0.51
Legs and Feet 1.00
1All correlations p,0.01.
doi:10.1371/journal.pone.0033281.t002
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Dissatisfaction with Appearance latent factor. Model parameters
are shown in Table 3. Fingertip-to-palm distance, the measure of
hand contractures, was significantly related to greater Dissatisfac-
tion with Appearance (0.07, p=0.036). Social Discomfort was
significantly associated with presence of upper-body telangiectasias
(0.32, p=0.021) as well as younger age (per year) (20.017,
p,0.001). Skin pigmentation changes were not significantly
associated with either factor, but there was some suggestion of
an association (Dissatisfaction with Appearance, 0.15, p=0.161;
Social Discomfort, 0.22, p=0.068). Education, race/ethnicity,
and sex were not associated with either Dissatisfaction with
Appearance or Social Discomfort at p,0.25, and their inclusion
reduced model fit, so they were not included in the model.
Discussion
This study found that, in multivariate analyses, both disease
factors and age were related to Dissatisfaction with Appearance
and Social Discomfort among people with SSc. The findings
Figure 1. Structural equation model of relationships with sociodemographic and disease variables.
doi:10.1371/journal.pone.0033281.g001
Table 3. Brief-SWAP Structural Equation Model of Relationships with Sociodemographic and Disease Variables.
Variables Dissatisfaction with Appearance Social Discomfort
Standardized
Regression Coefficientsp value
Standardized
Regression Coefficientsp value
Age 20.001 0.863 20.017 ,0.001
Married 20.16 0.138 20.19 0.104
Upper-body telangiectasias 0.04 0.774 0.32 0.021
Face skin involvement 0.18 0.016 0.23 0.006
Fingertip-to-palm distance 0.07 0.036 0.05 0.199
Hyper- and/or hypo-pigmentation change 0.15 0.161 0.22 0.068
Correlation of Dissatisfaction with Appearance
and Social Discomfort Factors
0.59
doi:10.1371/journal.pone.0033281.t003
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factors, as they were related to various disfiguring aspects of SSc,
including skin involvement, upper-body telangiectasias, and
disfigurement from hand contractures. Younger patients were
more socially uncomfortable than older patients; however, age was
not strongly related to Dissatisfaction with Appearance.
The associations of disfiguring physical changes with Dissatis-
faction with Appearance and Social Discomfort are not surprising.
For instance, relationships among extensive skin involvement,
decreased appearance self-esteem, and heightened dissatisfaction
with appearance have been documented previously in SSc
[4,30,31] and in other types of acquired disfigurements [32]. A
previous study, for instance, found that skin thickening was
associated with lower appearance self-esteem in a sample of
women with SSc [4]. Beyond SSc, previous research has
documented social anxiety and avoidance behaviours among
persons who have sustained visible disfigurement from a variety of
sources to the face and other socially relevant body parts [33]. This
is similarly reflected in the present study, as face skin involvement,
upper-body telangiectasias, and hand contractures – salient
physical changes that occur in visible and socially relevant body
parts – were significantly related to either Dissatisfaction with
Appearance or Social Discomfort. The current results also suggest
that skin pigmentation changes may be important for both factors.
It is of note that hands and fingers are visible and not easily hidden
from others with clothing, but skin involvement to these areas was
not associated with Dissatisfaction with Appearance or Social
Discomfort in the multivariate model once face involvement was
included. The hands and fingers variable was significant when face
was not included, however, and the fact that it was not significant
when added to the model after the face variable may be related to
the relatively high degree of association between the variables.
Preoccupation with appearance and its importance for meeting
new people, making social connections, and developing intimate
relationships is often more pronounced earlier in life, which may
account for the strong link in this study between age and Social
Discomfort. We found that, although age did not play a role in
individuals’ ratings of Dissatisfaction with Appearance, it was an
important factor in feelings of Social Discomfort. This finding is
consistent with the broader literature on people with changes to
their appearance due to illness and injury, which has found that
older age is generally associated with less distress related to body
image [13]. In the context of social interactions, particularly for
establishing intimate relationships, appearance is highly relevant.
Worry about a different or disfigured appearance can result in
heightened focus on appearance itself, as well as its social
consequences (e.g., thoughts of being disadvantaged in searching
for a partner) [6]. Taken together, these findings suggest that
younger patients may be at a greater risk of body image distress
related to Social Discomfort based on physical appearance.
However, the relatively small amount of variance explained by
sociodemographic variables and disease factors suggest that
psychological and personality variables may be important factors
in determining vulnerability to body image distress in SSc.
There are interventions that may be useful to reduce distress
relatedto thisbodyimageconcernfromSSc.Forinstance,cognitive-
behavioral therapy for social anxiety [5] and social skills training
programs [33,34] have been recommended as strategies to reduce
social avoidance and increase self-esteem in social settings for other
patient groups. Rheumatologists and other healthcare professionals
may consider providing patients with informational resources as a
starting point in providing support and in creating an atmosphere
where body image concerns and issues can be discussed among
SSc patients and healthcare providers. Changing Faces, a UK
not-for-profit organization (www.changingfaces.org.uk), for instance,
provides workshops, as well as a range of self-help informational
resources related to body image concerns from disfigurement.
There are some limitations to consider when interpreting results
from the current study. The sample consisted of a convenience
sample of SSc patients enrolled in the CSRG Registry; therefore, the
results may not represent the full spectrum of the SSc patient
population. The present sample of patients with SSc generally had
stable disease(meandisease duration 10.4 years).Patients whoarenot
cared for by a rheumatologist and patients with very severe SSc who
were too sick to participate or who died earlier in their disease course
were not included in the present study. This may have resulted in an
over-representation of healthier patients (survival cohort), and the
results may not be generalizable to the full spectrum of SSc. Related
to this, statistics on the number of patients approached versus
consented are not available for all CSRG centres, but it is estimated
that more than 80% of patients approached to participate in the
Registry do enroll. This study also used cross-sectional data that did
not allow for assessment over time. Additionally, apart from the
mRss, the measures of disfiguring aspects of SSc were rough and not
specifically validated. For instance, manifestations of telangiectasias
can be quite extensive and might contribute significantly to body
image issues; however, in the current sample, measurement of
telangiectasias was based on large body regions (i.e. scores across
upper body parts), scored as either present or absent, and
telangiectasias to specific body regions (e.g., hands or arms) could
not be assessed. Similarly, the method of measuring skin pigmenta-
tion changes was limited. Hyper- and/or hypo-pigmentation was
scored as either present, absent, or unknown, which is a general
scoring method, and may have limited the relationship between
pigmentation changes and body image distress in our models.
Additionally, the high proportion of White patients in our sample
may not reflect the body image changes that can occur with pigment
changes in other patients, and the high proportion of White patients
in the sample, relative to other ethnicities, made it impossible to
examine body image changes in other groups.
In sum, this study found that both Dissatisfaction with
Appearance and Social Discomfort were associated with numerous
disfiguring aspects of SSc. Furthermore, younger patients were
more prone to discomfort in social settings. The results of this
study underline the need to attend to both disease and social
contexts in understanding the impact of disfigurement on body
image distress among patients with SSc and to be aware that
multiple factors may contribute to patient concerns about their
appearance.
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